---
title: "UnitedHealth climbs on Q3 earnings beat and raised 2026 EPS guidance"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/302014438.md"
description: "UnitedHealth rose 3% during regular trading to $408.72 after reporting Q3 EPS of $4.69, well above estimates, and lifting full-year guidance."
datetime: "2026-10-15T19:12:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/302014438.md)
  - [en](https://longbridge.com/en/news/302014438.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/302014438.md)
generator: "portal-rs"
---

# UnitedHealth climbs on Q3 earnings beat and raised 2026 EPS guidance

联合健康 (UNH.US) 盘中出现快速波动，现报**408.72 美元**，当日涨幅**3.31%**。

公司于 10 月 15 日公布第三季度财报，每股盈利达**4.69 美元**，显著高于市场预期的 4.12 美元，医疗损失比率亦出现改善。基于强劲业绩表现，公司将 2026 年全年每股盈利指引上调至**20.50 美元**以上。

尽管 Raymond James 以估值考量为由将目标价下调至 450 美元，但仍维持跑赢大盘评级。Piper Sandler 与 Barclays 等机构也同步调整目标价，反映市场对利润率复苏的谨慎乐观态度。

### Related Stocks

- [UNH.US](https://longbridge.com/en/quote/UNH.US.md)

## Related News & Research

- [Weaver Capital Management LLC Makes New Investment in UnitedHealth Group Incorporated $UNH](https://longbridge.com/en/news/302086079.md)
- [BUZZ-Street View: UnitedHealth's rebound gathers pace as optimism grows](https://longbridge.com/en/news/301840001.md)
- [Crypto Strategist Who Nailed 2025 Bitcoin Top Warns BTC Could Drop Below $70,000 – Here’s His Price Target](https://longbridge.com/en/news/302980144.md)
- [Marqeta (MQ) Expands With Square And Coinbase, Is The Stock Still Undervalued?](https://longbridge.com/en/news/302983307.md)
- [Ultragenyx Pharmaceutical (RARE) Could Be 40% Undervalued As Turnaround Doubts Persist](https://longbridge.com/en/news/302973987.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**